![Model-based evidence shows SARS-CoV-2 vaccine boosters should be provided for those eligible ahead of winter Model-based evidence shows SARS-CoV-2 vaccine boosters should be provided for those eligible ahead of winter](https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_717778_16563245317819184.jpg)
Model-based evidence shows SARS-CoV-2 vaccine boosters should be provided for those eligible ahead of winter
![The effectiveness of COVID-19 vaccines against severe cases and deaths in Brazil from 2021 to 2022: a registry-based study - The Lancet Regional Health – Americas The effectiveness of COVID-19 vaccines against severe cases and deaths in Brazil from 2021 to 2022: a registry-based study - The Lancet Regional Health – Americas](https://www.thelancet.com/cms/attachment/38a16d41-c776-4fc9-92b7-a44009355d46/gr1.jpg)
The effectiveness of COVID-19 vaccines against severe cases and deaths in Brazil from 2021 to 2022: a registry-based study - The Lancet Regional Health – Americas
![Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months | FDA Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months | FDA](https://www.fda.gov/files/Booster%20Infographic_D_Rev_010622_0.png)
Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months | FDA
![Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study - The Lancet Respiratory Medicine Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/asset/00be3fb5-fa82-4da2-a7a9-39531ac92e64/gr1.jpg)
Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study - The Lancet Respiratory Medicine
![Should I get my COVID vaccine booster? Yes, it increases protection against COVID, including Omicron Should I get my COVID vaccine booster? Yes, it increases protection against COVID, including Omicron](https://images.theconversation.com/files/436537/original/file-20211209-25-x0e6wx.png?ixlib=rb-1.1.0&q=45&auto=format&w=754&fit=clip)
Should I get my COVID vaccine booster? Yes, it increases protection against COVID, including Omicron
![Frontiers | COVID-19 vaccine booster hesitancy (VBH) of healthcare professionals and students in Poland: Cross-sectional survey-based study Frontiers | COVID-19 vaccine booster hesitancy (VBH) of healthcare professionals and students in Poland: Cross-sectional survey-based study](https://www.frontiersin.org/files/Articles/938067/fpubh-10-938067-HTML/image_m/fpubh-10-938067-g001.jpg)
Frontiers | COVID-19 vaccine booster hesitancy (VBH) of healthcare professionals and students in Poland: Cross-sectional survey-based study
![Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales - The Lancet Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales - The Lancet](https://www.thelancet.com/cms/asset/43c19cc3-58f4-41c4-8c50-86f1f443c0fb/gr1.jpg)
Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales - The Lancet
![COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination — 24 U.S. Jurisdictions, October 3, 2021–December 24, 2022 | MMWR COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination — 24 U.S. Jurisdictions, October 3, 2021–December 24, 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/72/wr/social-media/mm7206a3_COVIDIncidenceBivalentBooster_IMAGE_10Feb2023_1200x675.jpg?_=67112)